Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Greek Helleniq Energy Group has purchased two wind projects in Romania and a photovoltaic project in the Bulgarian market as part of an international expansion.
The Board of the National Bank of Romania (BNR) decided on Friday to maintain the monetary policy interest rate at 6.50% per year.
The West Region is opening a new chapter with the signing of an agreement for the first regional investment accelerator, an initiative by the West Regional Development Agency (ADR Vest).
MOL Group reported a profit before tax of $236 million in the second quarter of 2025, marking a 56% year-on-year decrease. The company's performance was impacted by a slowing regional macroeconomic environment.
The Romanian media and entertainment industry is projected to experience constant growth over the next five years, reaching a value of €4.91 billion by 2029.